Medline MDLN
NASDAQ MDLN
$34.75 +0.06 (+0.17%)
As of: Sep 9, 2026 · 10:38 AM EDT

Medline (MDLN) Market Capitalization (2025 - 2026)

Medline's (MDLN) quarterly Market Capitalization came in at $51.1 billion in Q2 2026, down 5.97% quarter-over-quarter from $54.3 billion in Q1 2026.

Analysis

Medline (MDLN) Market Capitalization (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Market Capitalization for 2 consecutive years, with $51.1 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Market Capitalization changed N/A year-over-year to $51.1 billion in Q2 2026; TTM through Jun 2026 was $51.1 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $55.2 billion, changed N/A from the prior year.
  • Market Capitalization was $51.1 billion for Q2 2026 at Medline, down from $54.3 billion in the prior quarter.
  • Over five years, Market Capitalization peaked at $55.2 billion in Q4 2025 and troughed at $51.1 billion in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.51 Bn 48.65 Bn 2.32 Bn
2 Medline 29.85 Bn 27.17 Bn 2.22 Bn
3 West Pharmaceutical Services 24.00 Bn 23.56 Bn 329.20 Mn
4 Baxter International 12.94 Bn 10.79 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.54 Bn 5.43 Bn 100.91 Mn
6 Acme United 234.28 Mn 229.24 Mn 26.69 Mn
7 Rockwell Medical 31.04 Mn 6.24 Mn 3.24 Mn
8 Retractable Technologies 20.96 Mn -18.91 Mn 190,852.00
9 United Health Products 9.59 Mn 9.56 Mn -
10 Cuprina Holdings (Cayman) 8.14 Mn 5.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 51.10 Bn
Mar 28, 2026 54.35 Bn
Dec 31, 2025 55.19 Bn